Doctors explain how they're making the choice for their own kids
COVID-19 vaccines for some of the youngest children in the U.S. are now rolling out, and parents are faced with a new question: Moderna or Pfizer-BioNTech?for kids ages 6 months and up—are effective at preventing severe illness, and they both help prevent symptomatic infections. They offer vital protection in this age group, even for kids who have already recovered from COVID-19.
Moderna is also the “pretty clear” choice for Dr. Alpa P. Shah, a pediatrician in Milwaukee. Her 2-year-old daughter attends preschool at a school with elementary-aged kids, and Shah is worried about increased chances of exposure this fall as more children return to the classroom. “The timeline is much more friendly for the fall with Moderna,” she says.
Amin also likes the fact that the Pfizer vaccine has already been given to millions of children ages 5 and up, while Moderna was only available for U.S. adults until June 24, when the U.S. Centers for Disease Control and Prevention recommended its use in kids. That means there are more real-world data on Pfizer’s side effects among older children, including very rare side effects like myocarditis.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Interrupting treatment of patients on immune-suppressing medicine doubles antibody response to COVID-19 boosterA major clinical trial, led by experts at the University of Nottingham working in partnership with several universities and NHS hospitals, has found that interrupting the treatment of vulnerable people on long-term immune-suppressing medicines for two weeks after a COVID-19 booster vaccination doubles their antibody response to the booster.
Read more »
Recombinant SARS-CoV-2 harboring double reporters for COVID-19 surveillanceIn a recent article posted to the bioRxiv* preprint server, researchers at Texas Biomedical Research Institute, Georgia State University, and the University of Alabama at Birmingham developed a bireporter-expressing recombinant severe acute respiratory syndrome coronavirus 2 (rSARS-CoV-2) for tracking SARS-CoV-2 infection.
Read more »
COVID-19 fattens up our body's cells to help fuel its viral takeover, study suggestsResearchers tried using weight-loss drugs and other fat-targeting compounds to try to stop the virus in cell culture. The new study comes as infections rose in all four UK nations, with about 1.7 million having the virus last week.
Read more »
What can COVID-19 Teach us about Respiratory Disease?This article explores what COVID-19 has taught us to gain a better understanding of respiratory diseases.
Read more »
Covid-19 symptoms and isolation rules in Scotland as cases soarCovid-19 cases are on the rise again and while rules around the virus are far different than they were at the beginning, there is advice in place about what you should do if you test positive.
Read more »
The prevalence of long-COVID in children and adolescentsA recent study published in the Scientific Reports journal assessed the incidence of long-coronavirus disease (COVID) among adolescents and children.
Read more »